Clinical Trial Update: A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of VX-440 in combination with Tezacaftor/Ivacaftor in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (ivacaftor)
• Tezacaftor (Tezacaftor)
• VX-440

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED